HOME >> MEDICINE >> NEWS
Antabuse May Inhibit Fatal Reaction To Anesthetic

UW researchers have concluded studies that may eliminate a fatal problem associated with what is historically one of the most widely used anesthetic agents in the world.

In approximately one in 30,000 patients, the anesthetic agent halothane causes a condition known as "halothane hepatitis," which results in swift and fatal liver damage in approximately 50 percent of cases. For four decades, this problem has been recognized in anesthesia, yet the mechanism by which it occurs has been incompletely understood.

Drug metabolism is the process by which our bodies transform and eliminate the foreign compounds. Halothane is transformed in the liver into a molecule that binds to liver proteins. In most people, this process has no significance, but in some people these liver proteins stimulate the formation of antibodies that seriously damage the liver. The reason why some patients are susceptible remains a mystery.

In a study published in the Lancet in 1996, Dr. Evan Kharasch, professor of anesthesiolofy, identified P450 2E1 as the enzyme responsible for the metabolic step that triggers the formation of antibodies. More recently, Kharasch and colleagues have shown that they can chemically inhibit P450 2E1 from carrying out this unwanted intracellular mission by giving patients a drug called disulfiram before anesthesia.

"We manipulate the activity of the enzyme with disulfiram, known by the trade name Antabuse. We found that a single dose could 'turn off' P450 2E1," Kharasch said.

The disulfiram is itself transformed in the liver into a chemical that inactivates P450 2E1 by binding to it and preventing its catalytic activity. "By turning off this enzyme we can prevent the molecular pathway leading to halothane toxification, and by extrapolation, possibly prevent halothane hepatitis," he said.

Kharasch has identified the role of p450 2E1 in the metabolism of several other volatile anesthetics. The
'"/>

Contact: Will Morton
wmmorton@u.washington.edu
206-543-3620
University of Washington
3-Dec-1998


Page: 1 2

Related medicine news :

1. Inhibitors prevent aggresome formation associated with some forms of ALS
2. Inhibiting Growth Of New Blood Vessels Reduces Heart Disease Plaque In Mice
3. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw
4. New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs
5. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine
6. Dynavax Demonstrates Ability Of Immunostimulatory DNA Sequences To Inhibit Symptoms Of Allergic Asthma In Animal Model
7. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report
8. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
9. Answers To Access, Adherence And Tolerance Of Protease Inhibitors
10. ACE-Inhibitors Score High In Reducing Heart Attack Deaths
11. Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
Breaking Medicine Technology:
Cached News: